ARCHIVES

Novel Antifungal Agent Highly Active Against Esophageal Candidiasis

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

No Benefit To Shark Cartilage As Treatment, Large Trial Finds

July 27, 2007

In Brief: Gaus Heads AHCPR; Lineberger Names New Leadership In Oncology and Clinical Research

July 22, 1994

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

Some Of Show’s Screening Messages Not Widely Accepted.

September 12, 2008

Avastin Combination Approved For Metastatic Colorectal Cancer

February 22, 2013